|
|
|
|
||
Re: Pharma Japan: Celgene’s CAR-T Therapy Earns Orphan Status in Japan.....Let’s face it we have a disastrous CEO and management team, it’s incredibke how incompetent they are, that is why company trading at 7 X 2019 EPS. |
return to message board, top of board |